High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases

International Journal of Medical Microbiology - Tập 301 - Trang 475-479 - 2011
Cristiane M. Thomazini1,2, Danielle A.G. Samegima1,3, Maria A.M. Rodrigues2, Carlos R. Victoria4, Josias Rodrigues1,3
1UNESP-IBB/Institute of Biosciences, Department of Microbiology and Immunology, Botucatu, SP, Brazil
2UNESP-FMB/Faculty of Medicine, Department of Pathology, Botucatu, SP, Brazil
3USP-ICB/Institute of Biomedical Sciences, Post-Graduation Program in Microbiology, São Paulo, SP, Brazil
4UNESP-FMB/Faculty of Medicine, Department of Internal Medicine, Botucatu, SP, Brazil

Tài liệu tham khảo

Ardizzone, 2002, Inflammatory bowel disease: insights into pathogenesis and treatment, J. Int. Med., 256, 475, 10.1046/j.1365-2796.2002.01067.x

Berger, 2004, Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering Escherichia coli (Afa/Dr DAEC), Mol. Microbiol., 52, 963, 10.1111/j.1365-2958.2004.04033.x

Boudeau, 1999, Invasive Ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease, Infect. Immun., 67, 4499, 10.1128/IAI.67.9.4499-4509.1999

Campieri, 2001, Bacteria as the cause of ulcerative colitis, Gut, 48, 132, 10.1136/gut.48.1.132

Cravioto, 1979, An adhesive factor found in strains of Escherichia coli belonging to the traditional infantile enteropathogenic serotypes, Curr. Microbiol., 3, 95, 10.1007/BF02602439

Darfeuille-Michaud, 1998, Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease, Gastroenterology, 115, 1405, 10.1016/S0016-5085(98)70019-8

Frank, 2007, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc. Natl. Acad. Sci. U.S.A., 104, 13780, 10.1073/pnas.0706625104

Frankel, 1990, Detection of Shigella in feces using DNA amplification, J. Infect. Dis., 161, 1252, 10.1093/infdis/161.6.1252

Giaffer, 1992, Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease, Gut, 33, 646, 10.1136/gut.33.5.646

Jiang, 2002, Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers, J. Clin. Microbiol., 40, 4185, 10.1128/JCM.40.11.4185-4190.2002

Johnson, 2000, Improved repetitive element PCR fingerprinting for resolving pathogenic and nonpathogenic phylogenetic groups within Escherichia coli, Clin. Diagn. Lab. Immunol., 7, 265, 10.1128/CDLI.7.2.265-273.2000

Kaper, 2004, Pathogenic Escherichia coli, Nat. Rev. Microbiol., 2, 123, 10.1038/nrmicro818

Kotlowski, 2007, High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease, Gut, 56, 669, 10.1136/gut.2006.099796

Kuespert, 2006, CEACAMs: their role in physiology and pathophysiology, Curr. Opin. Cell Biol., 18, 565, 10.1016/j.ceb.2006.08.008

Martin, 2004, Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer, Gastroenterology, 127, 80, 10.1053/j.gastro.2004.03.054

Mylonaki, 2005, Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease, Inflamm. Bowel Dis., 11, 481, 10.1097/01.MIB.0000159663.62651.4f

Nataro, 1998, Diarrheagenic Escherichia coli, Clin. Microbiol. Rev., 11, 142, 10.1128/CMR.11.1.142

Nazli, 2004, Epithelia under metabolic stress perceive commensal bacteria as a threat, Am. J. Pathol., 164, 947, 10.1016/S0002-9440(10)63182-3

Rhodes, 2007, The role of Escherichia coli in inflammatory bowel disease, Gut, 56, 610, 10.1136/gut.2006.111872

Schultsz, 1997, Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls, J. Clin. Pathol., 50, 573, 10.1136/jcp.50.7.573

Seksik, 2003, Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon, Gut, 52, 237, 10.1136/gut.52.2.237

Silverberg, 2005, Toward an integrated clinical, molecular and serologic classification of inflammatory bowel disease: report from a working Party of the 2005 Montreal World congress of gastroenterology, Can. J. Gastroenterol., 19, 5, 10.1155/2005/269076

Steiner, 1998, Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells, J. Infect. Dis., 177, 88, 10.1086/513809

Swidsinski, 2002, Mucosal flora in inflammatory bowel disease, Gastroenterology, 122, 44, 10.1053/gast.2002.30294

Toma, 2003, Multiplex PCR assay for identification of human diarrheagenic Escherichia coli, J. Clin. Microbiol., 41, 2669, 10.1128/JCM.41.6.2669-2671.2003

Trabulsi, 2002, Typical and atypical enteropathogenic Escherichia coli, Emerg. Infect. Dis., 8, 508, 10.3201/eid0805.010385

Victoria, 2009, Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil, Arq. Gastroenterol., 46, 20, 10.1590/S0004-28032009000100009